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ABSTRACT

The cochlear implant has restored hearing to hundreds of thousands of prof

individuals since the early 1980s. The implant works by providing electri

directly to the auditory nerves, bypassing the damaged sensory processes.

elec
trodes of the cochlear implant are required to directly stimulate the a
the interface between these electrodes and the nervous system is a vital
function of the bionic device. However, in-term
caseshearing
of longloss the
oryaudit

nerve degenerates and auditory nerve processes, or neurites, retract away

cochlea and the intra
cochlear electrodes. This leads to a loss of effectivenes

cochlear implant. Currently the only remedy for this problem
ectrical
is to amplif

signals provided to the implant, but this causes shorter battery life due

currents and voltages and can potentially be damaging to the tissues in a
the cochlea. This work describes attempts to develop a an
material
be coated
which c

onto cochlear electrodes to preserve auditory nerves, potentially improvi
between the cochlear implant and the auditory nerve.

The material used throughout this work, polypyrrole, is a conducting poly

its unique pro
perties, polypyrrole can be used to incorporate and release ch

molecules with different electrical stimuli. The work presented within th

describes the development of polypyrrole to release nerve growth factors,

also known as neurotr
ophins, in order to improve auditory nerve survival and g

With delivery of nerve growth factor in response to the electrical stimul

the cochlear implant, it is hoped that better nerve survival will lead to

nerve/cochlear trode
elec interface, and better function of the implant. Extens

the release of radiolabelled neurotrophins from polypyrrole substrates we
under a variety of conditions in order to optimise both the material and

stimulatio
n used for controlled release. The focus of most work-3,
was
the
neurotro

member of the neurotrophin family of proteins that has the most widesprea
cell receptors.

Testingof the response of auditory nerve tissue dissected from that
rats showed
neurotrophins released from polypyrrole promoted the survival and
in growth
- iii
-

vitro
. From these experiments, it was determined that electrical stimulatio
effective in controlling the release of neurotrophins to improve
to aneurite

significant degree. Based on these
in vivo
results
experiments were undertaken, in which

guinea pigs were implanted with cochlear electrodes coated with polypyrro

these experiments, it was determined that electrical stimulation
otrophin
to promo

release helped not only to prevent implantation trauma, but also- to preve
related degeneration of auditory nerves observed in untreated cochleae.

Additionally, some further optimisation of the materials was completed. A

neurotro
phin, brain derived neurotrophic factor, has been shown to work syn

with neurotrophin
-3, and the release of both neurotrophins from a single poly
film was investigated. While the release of the proteins was not as well
effect of release on auditory nerve explants
in vitro
cultured
was significantly greater

than either neurotrophin alone. Studies exploring release
-3 from
of neurotrophin
PPy

coated on several novel substrates were performed, suggesting that biodeg

nanostructured materials can be used to further tailor the release of the
from polypyrrole. An implantable power- a
source
biobattery
- was also used to
electrically control the release of
-3,neurotrophin
highlighting the potential
a totally
for

implantable system for the controlled release of therapeutic molecules us
polypyrrole materials developed.

The insights gained in the course of this work may have implications for

release of other therapeutic molecules
om polypyrrole.
fr
Additionally, the informati

contained within this thesis could also have relevance beyond the scope o
implant/neural interface, with potential for use in other bionic devices

applications. The work describ
ed here demonstrates the potential to enhance nerv

electrode interfaces using polypyrrole to electrically control the releas
neurotrophins.
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BDNF and NT -3 were delivered by a-osmotic
mini
pump for 28 days. Scale bars shows 20 m.
Adapted from [124].
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Figure 2.7 ECIS plate used for sterile PPy deposition and subsequent culture of cells. Th
represents the common reference electrode, while the black circles indicate the worki
onto which PPy was deposited. Each well was
ually
individ
addressable, and the plates could be
used to perform electrical stimulation of polymers and cells under tissue
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Figure 3.2 Electrochemical cell for dual electrode stimulation
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Figure 3.3 Cyclic voltammetric growth of PPy/pTS without (a) and with
-3 added
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directio
n of the applied voltage.
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Figure 3.4 Cyclic voltammogram obtained using PPy/pTS as the working electrode in 0.2 M PB
7.4). The third scan is shown. Scan rate = 100 mV/sec. Arrows show the direction of t
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Figure 3.5 Proposed scheme for incorporation -of
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Figure 3.6 Film thickness of polymers grown under
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pTS and NT-3 at 2 g/mL. Each point represents the average of two samples, and the erro
show the range.
................................
................................
................................
............................
.69

Figure 3.8 Comparison of NT
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90 second
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Figure 3.11
- SEM images of PPy/pTS films grown for 10minutes
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Figure 3.12 Comparison of long term release -3offrom
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Figure 3.13 (a) Mass and (b) percentage-3ofreleased
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Figure 3.16 Comparison of -NT
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Figure 3.18
- Optimisat
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Figure 3.20
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Figure 3.21 Comparison of release -3offrom
NT PPy/pTS on microstructured, interdigitated electr
and a flat film electrode. Each data point shows the average of two measurements of r
stimulated by a clinical stimulator over
9% NaCl,
1 hourand
in the
0. error bars show the
..
84 range.

Figure 4.1 Anatomy of the cochlear, showing spiral ganglion neurons in cross section. Sou
University of Western Ontario Department of Anatomy and Cell Biology website
th
htt
p://instruct.uwo.ca/anatomy/530/earcoch.gif. (date
December
accessed:
2008).
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Figure 4.2 An example of the resulting voltage waveform when biphasic current pulses were
gold electrodes. Impedances were
lated
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from the voltage waveform using peak voltage outp
(Vt) as well as components
of
V V
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Figure 4.3 NT -3-induced neurite outgrowth from SGN explants. Representative images of SGN
explants grown on CAM
-coate
d tissue culture plastic with various concentrations
-3 added toof NT
the culture media. (a) In the absence
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explants grown in 20 ng/mL
-3 NT
(b), 40 ng/mL -3
NT(c) and 60 ng/mL-3NT(d) demonstra
ted
increased numbers of sprouting neurites. Scale bars
................................
are 100 m. ....................
97

Figure 4.4
- Validation of explant assay. SGN explants were plated onto plastic tissue cultu
coated with CAMs and cultured in media containing
80 ng/mL
0 NT-3. The number of neurites
growing out from SGN explants was counted proximal to the explant edge for each condi
bars represent standard error of the mean of over 15 replicates per data point (* p<0
the 0 ng/mL NT
-3 cont
rol).
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Figure 4.5 Neurite outgrowth from SGN explants on -c)
PPy.
show
(a explant growth on PPy/pTS,
while (d
-f) show growth on PPy/pTS/NT
-3. (a) and (d) are uncoated, untreated polymers, while
(c), (e) and (f) have
en coated
be
with CAMs. Additionally, extra
-3 wasNTincluded in culture
media at 40 ng/mL in (c) and (f). Scale bars
................................
are 100 m. ............................
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Figure 4.6 Comparison of neurite out growth on tissue culture platic (Plas), nd
PPy/pTS (PPy
PPy/pTS/NT-3 (PPy/NT-3), with and without CAMs and-3 NT
included in culture media at 40
ng/mL. Growth of explants on PPy/pTS/NT
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grown on tissue culture plastic or PPy/pTS (p<0.02). In addition,
nce of the
NT-3 in
prese
the
culture media or the addition of CAMs to plastic, PPy/pTS or-3PPy/pTS/NT
also resulted in
greater neurite outgrowth compared to the respective controls (p<0.01). Error bars re
standard error of the................................
mean.
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Figure 4.7 SEM images of explants grown on (a, b, d) PPy/pTS or (c,-3.
e)(a)
PPy/pTS/NT
Under low
power, explants appear as cells and neurites radiating from a central
A ?broblast
mass of tissue.
growing on PPy/pTS surface appears
?atascell
a
adhering to raised globules of PPy/pTS. (c)
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neurite extending from an explant (out of view on the left side of the picture) grows
another neurite in a fascicle (arrowhead) comes
and then
a single
be
neuron. A nerve branch is
visible (arrow). (d) Closer to the explant,
?bres can
nerve
grow very densely, interacting with bot
the PPy and other cells. (e) Growth cones are often visible at the growing tip of neu
the growt
h cone terminates on a raised PPy/pTS/NT
-3 nodule and is extending
?lopodium
a
(arrow).
................................
................................
................................
................................
...........
103

Figure 4.8 Impedance of gold and
-coated
PPy
electrodes. Impedances were calculated from the app
1.5 mA amplitude waveform, ge
volta
waveform (inset) and Ohms law. There was no difference i
Z t, Ra or Z
PPy/pTSgold electrodes and PPy/pTS/NT
-3p between plain gold electrodes, -coated
coated gold electrodes when measured in PBS at room temperature. Error bars denote th
error
of the mean. Values shown are representative of 4 independent
......................
experiments.
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Figure 4.9 Comparison of cumulative release
-125oflabelled
I
NT
-3 from stimulated (grey) and
unstimulated (black) 2 1PPy/pTS/NT
cm
-3 polymers at
various timepoints. Stimulated polymers
received only 1 hour of stimulation
-25 hours
at 24after being placed in release media. Error b
represent standard error of the mean of three
................................
replicates.
.............................
106

Figure 4.10 Effect short
of -term electrically
-stimulated release of
3 from
NT PPy on explant neurite
outgrowth. Explants were grown for 4 days on
-coated
CAM
PPy/pTS or PPy/pTS/NT
-3 and
subjected to a biphasic current pulse stimulus for 1 hour after 24 hours.
grown(a) shows e
on stimulated PPy/pTS/NT
-3 and (b) shows stimulated PPy/pTS. Scale bars are 100 m. (c)
compares the number of neurites per explant on both PPy/pTS -and
3 with
PPy/pTS/NT
and without
electrical stimulation. While no difference was observed
ationwith
on PPy/pTS
stimul (p = 1.0),
electrical stimulation significantly increased neurite outgrowth
-3 (*
on=PPy/pTS/NT
p<0.01).
Error bars represent standard error of the mean. PPy refers to PPy/pTS,
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to
PPy/pTS/NT-3 and stim refers to 1timulation.
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Figure 5.1 Chronopotentiograms of galvanostatic PPy growth with various dopants, as shown
2
key. PPy/pTS, PPy/DBS and PPy/PSS were grown at 2 mA/cm
and PPy/PMAS, PPy/HA and
2
PPy/CS were grown at 0.25cmmA/
.................................
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Figure 5.2 Photographs of 2 cm X 1 cm strips of PPy synthesised with various dopants. (a)
2
(b) PPy/DBS and (c) PPy/PSS were grown for 10 minutes at
and
2 mA/cm
(d) PPy/PMAS, (e)
2
PPy/HA and (f) PPy/CS were
rowng for 80 minutes at 0.25.................................
mA/cm
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Figure 5.3 Scanning electron microscope images of PPy synthesised with various dopants. (
2
PPy/pTS, (b) PPy/DBS and (c) PPy/PSS were grown at and
2 mA/cm
(d) PPy/PMAS, (e) PPy/HA
2
and (f) PPy/CS were grown at 0.25 mA/cm
. All polymers were grown for 60 minutes. The scale
bar represents 20
................................
m.
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Figure 5.4 Cyclic voltammogram using PPy films synthesised with various dopants as the wor
2
electrode.msFil
were synthesised for 10 min at 2(pTS,
mA/cmDBS and PSS dopants) or 80 min
2
at 0.25 mA/cm(PMAS, HA and CS) to standardise the amount of charge passed during depo
The potential was scanned between +0.6 -0.8
V and
V vs. Ag/AgCl using a platinum
counter
electrode in 1 M NaNO
at
a
scan
rate
of
10
mV/sec
for
5
cycles.
The
third
.........
scan
125 is shown.
3

Figure 5.5 Peak voltage separation in cyclic voltammograms recorded at 10 mV/sec
3 of in 1 M Na
PPy films grown withous
vari
dopants.
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Figure 5.6 Contact angle measurements of water on PPy films grown with various dopants. Ea
represents the mean of three measurements taken on separate films, and the error bars
standard erro
r of the mean.
# indicates that no accurate measure of contact angle of PPy/HA
be taken, and that the value
................................
is <10.
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Figure 5.7 Amount of NT
-3 incorporated into polypyrrole films grown with various sdopants. Po
2
2
were grown for 1 hour at 2 mA/cm
(pTS, DBS, PSS dopants) or 8 hours at 0.25
(PMAS,
mA/cm
2
HA, CS) so that the same amount of charge was passed
for per
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point shows the average of four replicates, with the ing
error
onebars
standard
show error of the
mean.................................
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Figure 5.8 (a) Electrically stimulated and (b) unstimulated cumulative-3mass
fromrelease
PPy
of NT
films grown with various dopants. Note-axis
that of
the(b)
y is at a different
le to (a)
scato allow
the unstimulated release from PPy films to be easily
................................
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131
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Figure 5.9 (a) Electrically stimulated and (b) unstimulated cumulative-3%from
release
PPy of NT
films grown with various dopants.
hatNote
the-axis
t
y
of (b) is at a different scale to (a) to a
the unstimulated release from PPy films to be easily
................................
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134
Figure 5.10 Native polyacrylamide gel electrophoresis
-3 withofvarious
NT
components oflms.
PPy fi
Well 1 shows unmodified -3,
NT well 2 shows -NT
3 mixed with pyrrole, wells
-8 show
3 NT-3
mixed with dopant molecules (3: pTS, 4: DBS, 5: PSS, 6: PMAS,
........................
7: HA, 8: 136
CS).

Figure 5.11 Native agarose gel electrophoresis
NT -3 with
of various components of PPy films. Well 1
shows unmodified -NT
3; well 2 shows-3NTmixed with pyrrole; wells
-8 show3 NT-3 mixed with
dopant molecules (3: pTS, 4: DBS, 5: PSS, 6: PMAS, 7: HA, 8: CS). The directions of t
and negative trode
elec within the gel electrophoresis setup are
............................
also indicated.
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Figure 5.12 Number of neurites extending from explants grown on various substrates includi
culture plastic and PPy films grown with various
Fordopants.
all experiments
-3 NT
was added
exogenously into the media at 40 ng/mL. The error bars show one standard error of the
over 20 replicates per
................................
point.
................................
................................
............
139
Figure 5.13 Microscope images of SGN explants grown on
ousvari
substrates, including (a) tissue
culture plastic, (b) PPy/pTS, (c) PPy/DBS, (d) PPy/PSS, (e) PPy/PMAS, (f) PPy/HA and
PPy/CS. NT
-3 was added exogenously into the media at................................
40 ng/mL.
.............
141

Figure 5.14 Increased neurite
utgrowth
o
from SGN explants with electrical stimulation of PPy gr
with various dopants to release
-3. Each
NT point represents the average
-43 replicates,
of 6
and the
error bars represent the standard error
................................
of the mean. ................................
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Figure 5.15 Images of SGN explants grown on electrically
-stimulated PPy synthesised with various
dopants
- (a) PPy/pTS, (b) PPy/DBS, (c) PPy/PSS, (d) PPy/PMAS, (e) PPy/HA 145
and (f) PPy/C

Figure 6.1
- Four
-ring platinum
ectrode
el
array for implantation in GPs. The electrode array consi
four active tapering electrodes individually wired for stimulation as electrode pairs
electrode as a marker for insertion depth. Diagram
................................
not to scale.
....................
151

Figure 6.2 A guinea pig electrode array coated with PPy/pTS implanted into a GP cochlea. T
electrode can be seen protruding from the cochleostomy in this example. The fifth unc
platinum extracochlear electrode is ................................
also visible. ................................
............
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Figure 6.3 Images of PPy/pTS growth on GP cochlear electrodes at several points during syn
the PPy. 40 minutes was determined to be the maximum deposition period for PPy/pTS gr
mA/cm 2, as growth for
gerlon
than this led to bridging of the individual
................
Pt electrodes.
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Figure 6.4 Chronopotentiograms of galvanostatic PPy/pTS growth on GP cochlear electrodes.
2
synthesised in
-electrode
a 2
electrochemical cellmaton
2 mA/c
the four platinum electrodes (with
2
a total area of 1.658
) simultaneously.
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Figure 6.5 Post
-growth cyclic voltammogram of PPy/pTS synthesised on GP cochlear electrodes
was performed at 10 mV/sec in 1 M3 NaNO
in a 3 electrode cell with a Pt mesh counter electr
and a Ag|AgCl reference electrode.
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Figure 6.6 Scanning electron microscope images of PPy/pTS grown on a platinum GP cochlear
electrode. Scale bars are 100 m,
and102 mm as marked.
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Figure 6.7 NT-3 release from PPy/pTS/NT
-3-coated GP cochlear electrodes. Release was electrical
stimulated for the first week (as marked), and then left unstimulated for a further w
represents a single measurement.
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Figure 6.8 Cross sectional images of the lower basal turn of guinea pig cochleae, showing
tissue response to-coated
PPy
GP cochlear electrode implantation. (a) shows
no fibrous
little to
tissue response (category 1 in Table 6.1), while (b) shows a large amount of fibrous
filling the scala tympani in which the electrodes were inserted (category 4 in Table
are 200 m as indicated.
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Figure 6.9 Comparison of change in average SGN densities between implanted and unimplanted
guinea pigs in different treatment groups. All groups -3
except
+ stim
for
showed
PPy/NT
a decrease
in SGN density with implantation ochlear
of the celectrodes due to insertion trauma. In the PP
group, there was a lower density of SGNs in the implanted cochlea compared to the uni
cochlea (first bar). This loss of SGNs was lessened in the PPyNT3 group, but not to s
levels (sec
ond bar). In PPyNT3
-stim GPs, there was significant survival of SGNs compared to
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unimplanted cochlea and compared to unstimulated groups, while there was a high degre
variability in the
-stim
PPy group. Error bars indicate the standard error
mean. of
*p<0.05
the
compared to the PPy group by ANOVA.
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Figure 6.10 Spiral Ganglion Neurons of cochleae implanted with PPy/pTS-3orcoated
PPy/pTS/NT
GP
cochlear electrodes without (top) or with (bottom) electrical
. The density
stimulation
of SGNs was
improved with stimulation and -3
with
inclusion
NT
in PPy coating of GP electrodes.
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Figure 7.1
- Sequence and structural summary-3 for
(top)
NT and BDNF (bottom), showing 3 disulphide
bonds typical
of cysteine knot growth factors (dotted green lines),
-sheetstrong
content
beta
(blue
arrows 53% of sequence for-3NT
and 55% for BDNF) and alpha
-helix structure in BDNF (red
curved lines 5% of sequence for BDNF). Images from Protein Data Banks analysi
of data
provided by [3].
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Figure 7.2
- Images of (a, c)
-3 and
NT (b, d) BDNF rendered from
-ray crystallography
X
of the proteins
by [3]. a) and b) show space fill renderings and c) and d) show ribbon cartoons illus
structural features. The colouring of the images is explained
...........................
in the colour
168 key.

Figure 7.3 Comparison of mass of BDNF from PPy/pTS/BDNF with and without electrical stimul
Each data point shows the mean ofeplicates,
three r and the error bars show one standard error
the mean.
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Figure 7.4 Response of SGN explants grown on tissue culture plastic with various concentra
BDNF added to the culture media.
-d) Representative
(a
images of SGNs. In the absence of BDNF
(a) and with the addition of 1 ng/mL (b) and 10 ng/mL BDNF (c), very few neurites wer
from explants. (d) Explants grown in 100 ng/mL BDNF demonstrated greater numbers of
resprouting neurites. Scale0 bar
m and
is 10
applies to all images. (e) Graph of mean neurites
SGN explant after 3 days culture in 0, 1, 10 or 100 ng/mL BDNF. Error bars represent
error of the mean. *p<0.05 compared to the 0 ng/mL ................................
BDNF control. ............
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Figure 7.5- Response of SGN explants to BDNF released from PPy/pTS/BDNF with and without
electrical stimulation. *p<0.01 compared to the PPy/pTS controls. Although there was
with electrical stimulation, there was no significant
between
difference
the unstimulated and
stimulated BDNF data.
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Figure 7.6 Comparison of incorporation of BDNF -3
and
into
NT PPy films. No significant difference
was seen between PPy films containing only one neurotrophin ms
andcontaining
PPy fil both
neurotrophins at 2 g/mL (PPy/pTS/BDNF/NT
-3). There was a slight decrease in the incorporat
with 1 g/mL of each neurotrophin in the polymerisation solution (1 g PPy/pTS/BDNF/NT
-3)
rather than 2 g/mL, which was significant incorporation
for BDNF
(* p<0.05). Each point is the
average of 6 replicates, and the error bars show one standard
..........................
error of the
179 mean.

Figure 7.7 Release of BDNF from PPy/pTS films with and without electrical stimulation.
ase
The
of BDNF alone is compared to the release of BDNF from dual neurotrophin films. Films
grown with both neurotrophins at 2 g/mL (BDNF/NT3), or with both neurotrophins at 1 g
(1 g BDNF/NT3). Each point represents the average of three
ments,
measure
and error bars are
not shown for clarity.
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Figure 7.8
- Release of -3
NTfrom PPy/pTS films with and without electrical stimulation. The re
NT -3 alone is compared to the release
-3 from
of NTdual neurotrophin
films. Films were grown
with both neurotrophins at 2 g/mL
-3/BDNF),
(NT
or with both neurotrophins at 1 g/mL (1 g
NT -3/BDNF). Each point represents the average of three measurements, and error bars a
shown for clarity.
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Figure 7.9 SGN response to neurotrophins released from PPy/pTS. Neurite extension was sign
increased with electrical stimulation for all polymers except PPy/pTS and PPy/pTS/BDN
(p<0.03). Both PPy samples containing both BDNF-3 and
significantly
NT
increased the neurite
outgrowth over either of the neurotrophins alone with electrical stimulation (p<0.01)
shows the average of
-6025measurements, with the error bars showing one standard error of
mean.................................
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Figure 7.10 Representative images of SGN explants grown on PPy films containing various
neurotrophins, with (right) and without (left) electrical
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stimulation.
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Figure 8.1 Cross
-section of one turn of hlea,
the coc
illustrating the position of the basilar membr
relative to the scala tympani, where the cochlear implant is inserted, and the cochle
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are situated. Source: Wikipedia article on the cochlea http://en.wikipedia.org/wiki/C
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accessed: 1December 2008).
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................................
................................
.............
201

Figure 8.5 Schematic diagra
m showing the steps involved in the process used for deposition of
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- General schematic image of Mg/conducting polymer
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Figure 8.9
- Cyclic voltammetric growth
of PPy/pTS/NT
-3 on a bare gold mylar electrode. 15 scans at
mV/sec between
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Figure 8.10 Scanning electro
n microscope images of CV
-grown PPy/pTS/NT-3 on Au -mylar
substrates. Two magnifications of films before and after one week of electrical stimu
shown, with the bars representing 100 m for the 400 X magnification images, and 10 m
5000 X magnification images.
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Figure 8.11 NT-3 release from flat
-grown
CV PPy/pTS films. (a) shows cumulative mass release fro
the films, and (b) shows cumulative % release over 1 week. Each point represents the
data oints,
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and the error bars show one standard error
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of the mean.
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Figure 8.12 Cyclic voltammetric growth of PPy/pTS/NT
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Figure 8.13- Scanning electron microscope images of 3D aligned MWNT forest substrates, eith
uncoated or coated with
-grown
CV PPy/pTS/NT
-3. Thr
ee magnifications of substrates are shown,
with the bars representing 100 m for the 400 x magnification images, 10 m for the 500
magnification images, and 2 m for the 20000 x magnification
................................
images. .......
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Figure 8.14
- NT-3 release from -CV
grown PPy/pTS films on 3D aligned MWNT forests. (a) shows
cumulative mass release from the films, and (b) shows cumulative % release over 1 wee
point represents the mean of 3 data points, and the error bars show the
one mean.
standard erro
................................
................................
................................
................................
........................
212

Figure 8.15
- Cyclic voltammetric growth of PPy/pTS/NT
-3 on PLGA electrospun fibre
-coated gold
electrodes. 15 scans at 50 mV/sec-0.6
between
and +1.0 V were performed to deposit PPy on the
cm X 1 cm substrate
. Grey arrows show direction ................................
of scans.
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Figure 8.16 Scanning electron microscope images of electrospun PLGA biodegradable substra
Substrates shown are uncoated, coated with
grownCVPPy/pTS/NT-3 after growth, and -PPy
coated substrates after 1 week-3of
release.
NT
Three magnifications are shown, with the bar
representing 100 m for the 400 X magnification images, 10 m for the 5000 X magnificat
images, and 2 m for the 20000 X magnification
................................
images.
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Figure 8.17 NT -3 release from CV
-grown PPy/pTS films on electrospun PLGA biodegradable
substrates. (a) shows cumulative % release from the films, and (b) shows cumulative m
over 1 week. Each
oint
p represents the mean ofpoints,
3 data and the error bars show one standard
error of mthe
ean.
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................................
................................
...........................
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Figure 8.18 Comparison of incorporat
ion of NT
-3 into CV
-grown PPy/pTS/NT
-3 deposited on various
substrates using identical
ions.
condit
................................
................................
............................
218

Figure 8.19 Release of NT
3 from CV-grown PPy layers deposited on three different substrates.
shows the average cumulative mass release from the films, and (b) showsweek.
% release ove
Each data point represents the meanoints.
of 3 data
Error
p bars are not shown
rity.
..........
for cla
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Figure 8.20- Scanning electron microscope images of-grown
VPP PPy/pTS/NT-3 on Au -mylar
substrates. Two magnifications of films before and after one week of electrical
on are
stimu
shown, with the barsesenting
repr
100 m for the 400 X magnification images, and 10 m for th
5000 x magnification
ages.
im
................................
................................
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Figure 8.21
- NT-3 release from flat
-grown
VPP PPy/pTS films. (a) shows cumulative
ease
mass
from
rel
the films, and (b) shows cumulative % release over 1oint
week.
represents
Each p
the mean of 3
data points, and the error bars show one standard
m ean.
error
................................
of the
.............
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Figure 8.22
- Scanning electron microscope
s of
image
3D aligned MWNT forest substrate, without (top
and with (middle + bottom)
-3 incorporated
NT
into the VPP PPy layer. Substrates that have
NT -3 stuffed into the VPP PPy layer are shown immediately after incorporation (middle
1 week of NT
-3 release (bottom). Three magnifications are shown, with the bars represen
m for the 400 X magnification
images, 10 m for the 5000 X magnification images, and 2 m fo
the 20000 X magnification
ages.
im
................................
................................
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Figure 8.
23 - NT-3 release from -VPP
grown PPy/pTS films in 3D aligned MWNT forest substrates. (a
shows cumulative mass release from the films, and (b) shows cumulative % release over
Each point represents the mean of 3 data points, and the one
error
standard
bars show
error of the
m ean.................................
................................
................................
................................
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Figure 8.24 Scanning electron microscope images of 2D aligned MWNT substrates. Substrates
are uncoated, coated with
-grown
VPP PPy/pTS/NT
-3 after growth, and
-coated
PPy
substrates
er aft
1 week of NT
-3 release. Three magnifications are shown, with the bars representing 100
400 x magnification
images, 10 m for the 5000 x magnification images, and 2 m for the 200
magnificationages.
im ................................
................................
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Figure 8.25
- NT-3 release from -VPP
grown PPy/pTS films on 2D aligned MWNT substrates. (a) shows
cumulative % release from the films, and (b) shows cumulative mass release over 1 wee
point represents the mean of 3 data points, and the ne
error
standard
bars show
erroro of
m ean.
the
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................................
................................
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Figure 8.26 Comparison of incorporati
on of NT
-3 into VPP
-grown PPy/pTS/NT
-3 deposited on various
substrates using identical
ions.
condit
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Figure 8.27
- Relea
se of NT
-3 from VPP
-grown PPy layers deposited on three different substrates.
shows cumulative mass release from the films, and (b) shows cumulative % release over
Each point represents the mean of 3 data points, and the errorndard
bars error
show one
of the
sta
m ean.................................
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Figure 8.28 Comparison of mass NT
-3 release from all novel substrates. (a) show release wit
electrical stimulation, whole (b)
assive,
showsunstimulated
p
release from the substrates. Each
represents the mean of 3 ents.
experim
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Figure 8.29 Preliminary study on release
-3 of
from
NT PPy using biobattery with paper spacer and
LiCl electrolyte. Each point represents the mean of 2 data points, and
shown
thethe
error bars
range.................................
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Figure 8.30 Mass of NT
-3 released from PPy stimulated by biobatteries with various electroly
data point esents
repr
the average of two data points, with the error bars showing
r
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of the
m ean.................................
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...............................
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Figure 8.31 Current and voltage values measured during-stimulated
electrically
release -of
3 from
NT
PPy using various electrolytes in a biobattery.
presents
Each point
the mean
re
of two data points,
and la
rge standard error bars have been omitted
rity.
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